Jyotsna Ghai - Oct 2, 2024 Form 4 Insider Report for Singular Genomics Systems, Inc. (OMIC)

Role
Chief Operating Officer
Signature
/s/ Dalen Meeter, Attorney-in-Fact
Stock symbol
OMIC
Transactions as of
Oct 2, 2024
Transactions value $
$0
Form type
4
Date filed
10/3/2024, 06:00 PM
Previous filing
Aug 13, 2024
Next filing
Nov 13, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction OMIC Common Stock Options Exercise +1.67K +277.67% 2.27K Oct 2, 2024 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction OMIC Restricted Stock Units Options Exercise -1.67K -24.99% 5K Oct 2, 2024 Common Stock 1.67K Direct F2, F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares of Common Stock issued pursuant to settlement of vested Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock.
F2 On June 26, 2024, the Issuer effected a 1-for-30 reverse stock split of its common stock (the "Reverse Stock Split"). The amount of securities reported on this Form 4 has been adjusted to reflect the Reverse Stock Split.
F3 Each RSU represents a contingent right to receive one share of the Issuer's Common Stock.
F4 25% of the RSUs vested on October 2, 2024; the remainder of the RSUs vest in 12 equal quarterly installments thereafter, beginning on January 2, 2025.